Paul De Souza

6PUBLICATIONS
28CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Consumption and everyday lifeLiquid biopsiesMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 27, 2026
Chemotherapeutic Potential of Fluorouracil-Platinum (IV) Prodrugs Against Cisplatin-Resistant Colorectal Cancer Cells.

Maria George Elias, Aleen Khoury, Shadma Fatima

|Oct 25, 2023
Alcohol consumption and health-related quality of life in regional, rural and metropolitan Australia: analysis of cross-sectional data from the Community Health and Rural/Regional Medicine (CHARM) study.

Lisa Redwood, Karli Saarinen, Rowena Ivers

|Apr 12, 2022
Harnessing Liquid Biopsies to Guide Immune Checkpoint Inhibitor Therapy.

Shadma Fatima, Yafeng Ma, Azadeh Safrachi

|Jan 11, 2022
Biomarkers of Castrate Resistance in Prostate Cancer: Androgen Receptor Amplification and T877A Mutation Detection by Multiplex Droplet Digital PCR.

Francis P Young, Therese M Becker, Mohammed Nimir

|Aug 30, 2019
The impact of neutrophil-lymphocyte ratio on risk reclassification of patients with advanced renal cell cancer to guide risk-directed therapy.

Angelina Tjokrowidjaja, David Goldstein, H Malcolm Hudson

|Jul 11, 2019
Detection of AR-V7 in Liquid Biopsies of Castrate Resistant Prostate Cancer Patients: A Comparison of AR-V7 Analysis in Circulating Tumor Cells, Circulating Tumor RNA and Exosomes.

Mohammed Nimir, Yafeng Ma, Sarah A Jeffreys

Pageof 1

Frequent Collaborators

3 joint publications

Yafeng Ma

3 joint publications

Therese M Becker

2 joint publications

Mohammed Nimir

2 joint publications

Kieran F Scott